US Patent Issued to GLAXOSMITHKLINE BIOLOGICALS on Sept. 23 for "Modified human cytomegalovirus proteins" (Maryland Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,949, issued on Sept. 23, was assigned to GLAXOSMITHKLINE BIOLOGICALS SA (Rixensart, Belgium).

"Modified human cytomegalovirus proteins" was invented by Marco Biancucci (Rockville, Md.), Sumana Chandramouli (Rockville, Md.) and Newton Muchugu Wahome (Rockville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Modified HCMV gB proteins in a non-post-fusogenic conformation, compositions comprising such proteins, and uses thereof."

The patent was filed on July 22, 2020, under Application No. 17/628,351.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&...